DK117316B - Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus. - Google Patents

Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus.

Info

Publication number
DK117316B
DK117316B DK579067AA DK579067A DK117316B DK 117316 B DK117316 B DK 117316B DK 579067A A DK579067A A DK 579067AA DK 579067 A DK579067 A DK 579067A DK 117316 B DK117316 B DK 117316B
Authority
DK
Denmark
Prior art keywords
equine
porcine
polyfunctional
against human
avian influenza
Prior art date
Application number
DK579067AA
Other languages
English (en)
Inventor
G Werner
Original Assignee
Rhone Poulenc Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sa filed Critical Rhone Poulenc Sa
Publication of DK117316B publication Critical patent/DK117316B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK579067AA 1966-11-21 1967-11-20 Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus. DK117316B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR84337A FR1538322A (fr) 1966-11-21 1966-11-21 Procédé de préparation d'une suspension virale inactivée

Publications (1)

Publication Number Publication Date
DK117316B true DK117316B (da) 1970-04-13

Family

ID=8621311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK579067AA DK117316B (da) 1966-11-21 1967-11-20 Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus.

Country Status (15)

Country Link
US (1) US3655871A (da)
AT (1) AT275733B (da)
BE (1) BE706781A (da)
CH (1) CH477552A (da)
DE (1) DE1617779A1 (da)
DK (1) DK117316B (da)
ES (1) ES347412A1 (da)
FI (1) FI43766B (da)
FR (1) FR1538322A (da)
GB (1) GB1183506A (da)
GR (1) GR33293B (da)
IL (1) IL28977A (da)
NL (1) NL6715369A (da)
SE (1) SE365542B (da)
YU (1) YU31920B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4158054A (en) 1973-10-18 1979-06-12 Duncan Flockhart & Co. Ltd. Preparation of virus sub-unit vaccines
US4000257A (en) * 1975-12-22 1976-12-28 American Cyanamid Company Process for the purification of influenza virus vaccine
US4500513A (en) * 1979-05-15 1985-02-19 Miles Laboratories, Inc. Influenza vaccine production in liquid cell culture
USRE33164E (en) * 1979-05-15 1990-02-13 Mobay Corporation Influenza vaccine production in liquid cell culture
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US4841023A (en) * 1986-06-25 1989-06-20 New York Blood Center, Inc. Inactivation of viruses in labile protein-containing compositions using fatty acids
US5639461A (en) * 1994-09-30 1997-06-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Influenza machine
DE69525659D1 (de) * 1995-10-20 2002-04-04 Yissum Res Dev Co Grippe-impfstoff
AUPQ486699A0 (en) * 1999-12-23 2000-02-03 Aruba International Pty Ltd A method of treating infectious diseases
US20090017069A1 (en) 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US20060060520A1 (en) 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
US6991727B2 (en) 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
AU2002322284A1 (en) 2001-06-25 2003-01-08 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material
US11865172B2 (en) 2005-04-21 2024-01-09 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US7959929B2 (en) 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
US20090181362A1 (en) * 2005-09-02 2009-07-16 Yasuo Suzuki Method for determination of recognition specificity of virus for receptor sugar chain
US9901631B2 (en) 2012-01-10 2018-02-27 The Broad Institute, Inc. Method and cells for the production of viral vaccines

Also Published As

Publication number Publication date
ES347412A1 (es) 1969-01-16
SE365542B (da) 1974-03-25
CH477552A (fr) 1969-08-31
NL6715369A (da) 1968-05-22
DE1617779A1 (de) 1972-03-23
US3655871A (en) 1972-04-11
GR33293B (el) 1967-11-21
BE706781A (da) 1968-05-20
FR1538322A (fr) 1968-09-06
AT275733B (de) 1969-11-10
IL28977A (en) 1972-05-30
YU31920B (en) 1974-02-28
GB1183506A (en) 1970-03-11
FI43766B (da) 1971-03-01
YU226867A (en) 1973-08-31

Similar Documents

Publication Publication Date Title
DK117316B (da) Fremgangsmåde til fremstilling af mono- eller polyfunktionelle vacciner mod human-, heste-, svine- eller fugleinfluenzavirus.
DK126643B (da) Duftstofegenskaber udvisende γ,δ-umættede aldehyder.
DK114289B (da) Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.
BE800320A (fr) Trepan au diamant,
DK108985C (da) Fremgangsmåde til fremstilling af mæslingevaccine indeholdende levende, svækket mæslingevirus.
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK104899C (da) Fremgangsmåde til fremstilling af en virusvaccine, navnlig mod panleukopenia.
DK121316B (da) Fremgangsmåde til afsvækkelse af levende mæslingevirus.
DK104193C (da) Fremgangsmåde til stabilisering af labile, antigene virusmaterialer.
DK114644B (da) Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.
DK124340B (da) Fremgangsmåde til fremstilling af stærk svækket, levende Newcastle-syge-virus-vaccine.
DK110208C (da) Fremgangsmåde til fremstilling af influenza-vacciner.
DK116736B (da) Fremgangsmåde til fremstilling af 5-chlor-2,3-pyridindiol.
DK113866B (da) Fremgangsmåde til fremstilling af somatiske antigenvacciner.
DK102794C (da) Fremgangsmåde til fremstilling af N-methyl-2,2-diphenyl-3-hydroxypropyl-carbamat.
DK122823B (da) Fremgangsmåde til fremstilling af en vaccine imod Rhinopneumonitisvirusinfektion på heste.
DK125654B (da) Fremgangsmåde til fremstilling af et antibiotisk aktivt complex thiopeptin eller dets komponenter thiopeptin A1, thiopeptin A2, thiopeptin A3 og thiopeptin B.
FR2774M (fr) Vaccins antigenes somatiques.
DK121811B (da) Fremgangsmåde til fremstilling af mæslingevaccine.
DK128503B (da) Fremgangsmåde til forøgelse af aktiviteten af en vaccine.
DK132206B (da) Anæstesiapparat eller lignende behandlingsapparat.
DK113285B (da) Fremgangsmåde til fremstilling af α-acetyleniske, ω-halogenerede ketoner.
DK102929C (da) Fremgangsmåde til sterilisering af vandige kompositioner.
DK112953B (da) Fremgangsmåde til fremstilling of mono- eller diamido-1,4-benzoquinoner.
DK129468B (da) Fremgangsmåde til dyrkning af virus.